Atara Biotherapeutics Inc
NASDAQ:ATRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
US |
|
R
|
Renault SA
F:RNL1
|
FR |
|
C
|
CAP SA
SGO:CAP
|
CL |
|
Koninklijke Ahold Delhaize NV
OTC:ADRNY
|
NL |
Wall St Price Targets
ATRA Price Targets Summary
Atara Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for ATRA is 9.52 USD with a low forecast of 4.04 USD and a high forecast of 18.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATRA's stock price target?
Price Target
9.52
USD
According to Wall Street analysts, the average 1-year price target for ATRA is 9.52 USD with a low forecast of 4.04 USD and a high forecast of 18.9 USD.
What is the Revenue forecast for Atara Biotherapeutics Inc?
Projected CAGR
-5%
The compound annual growth rate for Revenue over the next 8 years is -5%.
What is the Operating Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 5 years is 2%.
What is the Net Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
-2%
The compound annual growth rate for Net Income over the next 8 years is -2%.
